As a convenient, once-daily oral pill that delivers meaningful weight loss, this is obesity care designed for the real world. Shafipour said more research is needed before its known whether Foundayo can produce long-term results
However, even intensive behavioral interventions rarely match the weight maintenance achieved by continuing medication at lower doses
Retatrutide is an investigational medicine that has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
When used together without proper planning or medical guidance, you could increase the risk of nutrient deficiencies, low energy, or unwanted muscle loss
At lower doses, GLP-1 helps regulate cravings, reduces late-night snacking cycles, and supports a mild caloric deficit without tanking energy levels
10.1093/cvr/cvm005 80